Cell therapies in ovarian cancer
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359211008399
Abstract: Epithelial ovarian cancer (EOC) is the most important cause of gynecological cancer-related mortality. Despite improvements in medical therapies, particularly with the incorporation of drugs targeting homologous recombination deficiency, EOC survival rates remain low. Adoptive cell… read more here.
Keywords: cell therapies; oncology; ovarian cancer; cancer ... See more keywords
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.14021
Abstract: Gynecological cancers are known for being very aggressive at their advanced stages. Indeed, the survival rate of both ovarian and endometrial cancers is very low when diagnosed lately and the success rate of current chemotherapy… read more here.
Keywords: chemoresistance; chemoresistance targeted; ovarian endometrial; therapies ovarian ... See more keywords
New Therapies for Ovarian Cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2018.0034
Abstract: In the latest NCCN Guidelines for Ovarian Cancer, the histologic subtypes of ovarian cancer are described in more depth as they vary by frequency, typical age and disease stage at presentation, treatment recommendations, and survival… read more here.
Keywords: cancer; new therapies; ovarian cancer; therapies ovarian ... See more keywords